Global Health Data Exchange - Discover the World's Health Data

Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint

Nav

General Info
Geography 
France (FRA)
French Guiana
Coverage type 
Country
Time period covered 
07/2020 - 07/2020
Data type
Scientific literature
Summary 

"The overall seroprevalence was 15.4% [9.3%-24.4%] among 480 participants, ranging from 4.0% to 25.5% across the different municipalities. The seroprevalence did not differ according to gender (p=0.19) or age (p=0.51). Among SARS-CoV-2 positive individuals, we found that 24.6% [11.5%-45.2%] reported symptoms consistent with COVID-19."

Keywords 
Blood tests, COVID-19, Disease outbreaks, Infectious diseases, Medical tests
GHDx Entry last modified on: Mar 14, 2022